Member Info for Gheko

Market cap still only micro circa £4 million.

Director buying and excellent high energy presentations no funding concerns.

Working with US National Cancer Institute and our platforms attracting serious attention.

No wonder the re rate is gathering pace. Clear the incoming 5p level and chart looking at 7.5p next.

I like the hint in the presentation of more and bigger announcements to come.

Onwards and upwards

With a market cap for BELL at circa £20 million then the 1.5% sold by TEK raises them merely £300,000. Price still weak so placing incoming?

I repeat what I wrote a short while ago……….

Sea - I agree I don’t see this closing the valuation gap until TEK start selling some stakes and returning to shareholders or use for developing the 5th portfolio opportunity in AI.

Otherwise my fear is another fundraise soon as last one for circa £2 million was mostly used up in repayment of 600k loan, 500k for new AI and 300k for Guident fit out. That was in Feb so must be due another unless we sell some shares.

Looking like another raise whilst pushing the realisation of value by selling some of the portfolio further down the road. Silence is deafening as they say.

Another director purchase. Prepare the rockets 🚀

So we have the CEO buying shares and post the results we have a results presentation this Thursday at 3pm with a trading update.

Great opportunity to set out how the sales pipeline is really getting traction and no fund raise required with cash runway to 2025.

Major re rate gotta be coming and with further news on the tie up with the US National Cancer Institute then the rockets will well and truly be lit.

Looking forward to build up to Thursday and beyond.

In first RNS that the product is available on Amazon from October, later corrected to ‘online’.

The yanks will be hitting their Amazon prime all across the vast country buying our product. Lovely. Kerching.

Come on LSE, show the RNS on this site please!

Sea - I agree I don’t see this closing the valuation gap until TEK start selling some stakes and returning to shareholders or use for developing the 5th portfolio opportunity in AI.

Otherwise my fear is another fundraise soon as last one for circa £2 million was mostly used up in repayment of 600k loan, 500k for new AI and 300k for Guident fit out. That was in Feb so must be due another unless we sell some shares.

Been loyal to this share as believe in all they trying to achieve.

However share price wise I think what is holding us back is the silence in funding.

We raised circa $4.2 million six months ago. In June as part of the operations update Vlad reported

‘ We are diligently pursuing non-dilutive financing options to support these initiatives and remain focused on translating our scientific discoveries into clinical success. We look forward to updating our shareholders and the market as we continue to make strides in our development programs."

Since then silence. Really need a funding partner imho otherwise I see any other funding option as likely to be a further drag on share price.

Be great to get funding news sorted.

Heavy 500,000 block buying. Takeover inbound?

Nice summary Jimi.

To add to the mix Cheek leaving with immediate effect by mutual agreement suggests maybe a conflict of interest.

That easily could be he was looking at selling out to a major and being part of that buyout. Certainly interesting and by the look of the size and amount of buying the takeover story could have legs.

Good luck all.

Lovely news from across the pond. Share price started to re rate and all before NICE news.

SPQSTRADER - great summary if you don’t mind me saying and sums up why this is a winner with global sales.

Market cap still tiny for the colossal world wide revenues this will bring in. And that’s just two products. R&D will no doubt come up with further tests to meet a needy market.

Good support level on the share price ready to climb to new levels. Wanted more today but my broker hit by the outage. So please no RNS Monday so I can take advantage of current price read6 for the big action to come.

Have a good weekend all.

Come on MMs move the price up to get some shares! Some of us willing to pay a bit more to top up but NT for even £500 at mo on Barclays and I want 4K worth.

NICE news inbound. Multibagger inbound!

Bought some no problem. Barclays showing 2.15-2.25

Wow, if ever there was a huge hint that this year is the springboard of explosive growth this was it. Tiny market cap so immediate upside is a few bags before even gathering pace.

Loaded some more and happy to see this play out.

The RNS was intended to put good news out there as to the changing environment for pharma etc. unfortunately some read it as negative so this presentation should enhance the positive outlook.

Opportunity to smash it out the park and FAB arriving on many investors radars. Let’s hope so. Market cap minuscule for what they have.

Good pass on Hull thank you. A good find. I like the summary at the end which states,

‘PON-based fiber access is growing around the globe. There continues to be new, large opportunities for PON equipment and component vendors. In addition, POL is gaining momentum, reflecting PON’s penetration into the LAN market. The PON component and equipment market continues to be in the “growth” stage’.

And the hint at contracts in last RNS will land v soon imho. Ultra fast (see what I did there!) growth story.

I like towards the end of the interview where he states we are already in Phase 1 trials with everything going on. I read that as the prep and getting ready to start to start injecting patients which we all hope will provide a cure for these folk.